The International Staging System (ISS) for MM was published in 2005 to provide a simple method using readily available lab tests, serum beta2-microglobulin, and serum albumin, to classify MM patients for treatment including experimental treatment [13]. The gene discussed is ALB; the disease is Miyoshi myopathy.